{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:47:55Z","timestamp":1781920075626,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:00:00Z","timestamp":1477094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jdcr.2016.10.009","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T17:01:50Z","timestamp":1481130110000},"page":"502-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Idiopathic erythema multiforme: Evidence of underlying Janus kinase\u2013signal transducer and activator of transcription activation and successful treatment with tofacitinib"],"prefix":"10.1016","volume":"2","author":[{"given":"William","family":"Damsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2016.10.009_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007","volume":"62","author":"Wetter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejmg.2015.03.002","article-title":"Phenotype and genotype in 103 patients with tricho-rhino-phalangeal syndrome","volume":"58","author":"Maas","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jdcr.2016.10.009_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/1346-8138.12511","article-title":"A novel TRPS1 mutation in a family with tricho-rhino-phalangeal syndrome type 1","volume":"41","author":"Fujisawa","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/1346-8138.12111","article-title":"Trichorhinophalangeal syndrome with low expression of TRPS1 on epidermal and hair follicle epithelial cells","volume":"40","author":"Ito","year":"2013","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ydbio.2007.10.001","article-title":"Trps1 regulates proliferation and apoptosis of chondrocytes through Stat3 signaling","volume":"312","author":"Suemoto","year":"2007","journal-title":"Dev Biol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"155","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib8","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","article-title":"Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis","volume":"134","author":"Craiglow","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2016.10.009_bib10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMc1412997","article-title":"Remission of recalcitrant dermatomyositis treated with ruxolitinib","volume":"371","author":"Hornung","year":"2014","journal-title":"N Engl J Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512616301278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512616301278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:17:21Z","timestamp":1762474641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512616301278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2352512616301278"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2016.10.009","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic erythema multiforme: Evidence of underlying Janus kinase\u2013signal transducer and activator of transcription activation and successful treatment with tofacitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}